Hartford Financial Management’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-50
| Closed | -$541 | – | 394 |
|
|
2023
Q4 | $541 | Hold |
50
| – | – | ﹤0.01% | 386 |
|
|
2023
Q3 | $325 | Hold |
50
| – | – | ﹤0.01% | 388 |
|
|
2023
Q2 | $900 | Hold |
50
| – | – | ﹤0.01% | 360 |
|
|
2023
Q1 | $1.18K | Hold |
50
| – | – | ﹤0.01% | 363 |
|
|
2022
Q4 | $1.25K | Hold |
50
| – | – | ﹤0.01% | 358 |
|
|
2022
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 355 |
|
|
2022
Q2 | $2K | Hold |
50
| – | – | ﹤0.01% | 360 |
|
|
2022
Q1 | $2K | Hold |
50
| – | – | ﹤0.01% | 369 |
|
|
2021
Q4 | $3K | Hold |
50
| – | – | ﹤0.01% | 341 |
|
|
2021
Q3 | $3K | Hold |
50
| – | – | ﹤0.01% | 363 |
|
|
2021
Q2 | $2K | Hold |
50
| – | – | ﹤0.01% | 366 |
|
|
2021
Q1 | $3K | Hold |
50
| – | – | ﹤0.01% | 365 |
|
|
2020
Q4 | $3K | Hold |
50
| – | – | ﹤0.01% | 324 |
|
|
2020
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 309 |
|
|
2020
Q2 | $2K | Hold |
50
| – | – | ﹤0.01% | 324 |
|
|
2020
Q1 | $2K | Hold |
50
| – | – | ﹤0.01% | 327 |
|
|
2019
Q4 | $6K | Hold |
50
| – | – | ﹤0.01% | 308 |
|
|
2019
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 344 |
|
|
2019
Q2 | $2K | Hold |
50
| – | – | ﹤0.01% | 349 |
|
|
2019
Q1 | $3K | Hold |
50
| – | – | ﹤0.01% | 344 |
|
|
2018
Q4 | $1K | Buy |
+50
| New | +$1K | ﹤0.01% | 391 |
|